Krka d. d (KRK) - Net Assets
Based on the latest financial reports, Krka d. d (KRK) has net assets worth zł2.64 Billion PLN (≈ $726.57 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł3.34 Billion ≈ $918.05 Million USD) and total liabilities (zł695.76 Million ≈ $191.48 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how strategically is Krka d. d's equity deployed to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | zł2.64 Billion |
| % of Total Assets | 79.14% |
| Annual Growth Rate | 5.58% |
| 5-Year Change | 23.93% |
| 10-Year Change | 64.65% |
| Growth Volatility | 3.05 |
Krka d. d - Net Assets Trend (2010–2025)
This chart illustrates how Krka d. d's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see how much is Krka d. d worth.
Annual Net Assets for Krka d. d (2010–2025)
The table below shows the annual net assets of Krka d. d from 2010 to 2025. Also explore KRK net asset momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | zł2.38 Billion ≈ $654.54 Million |
+6.28% |
| 2024-12-31 | zł2.24 Billion ≈ $615.87 Million |
+2.57% |
| 2023-12-31 | zł2.18 Billion ≈ $600.45 Million |
+2.02% |
| 2022-12-31 | zł2.14 Billion ≈ $588.55 Million |
+11.43% |
| 2021-12-31 | zł1.92 Billion ≈ $528.16 Million |
+9.55% |
| 2020-12-31 | zł1.75 Billion ≈ $482.12 Million |
+5.06% |
| 2019-12-31 | zł1.67 Billion ≈ $458.92 Million |
+8.26% |
| 2018-12-31 | zł1.54 Billion ≈ $423.90 Million |
+3.53% |
| 2017-12-31 | zł1.49 Billion ≈ $409.44 Million |
+2.99% |
| 2016-12-31 | zł1.44 Billion ≈ $397.53 Million |
+2.74% |
| 2015-12-31 | zł1.41 Billion ≈ $386.95 Million |
+4.00% |
| 2014-12-31 | zł1.35 Billion ≈ $372.06 Million |
+1.45% |
| 2013-12-31 | zł1.33 Billion ≈ $366.75 Million |
+7.42% |
| 2012-12-31 | zł1.24 Billion ≈ $341.41 Million |
+8.84% |
| 2011-12-31 | zł1.14 Billion ≈ $313.68 Million |
+8.21% |
| 2010-12-31 | zł1.05 Billion ≈ $289.89 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Krka d. d's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 29.7% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | zł601.09 Million | 25.47% |
| Common Stock | zł54.76 Million | 2.32% |
| Other Comprehensive Income | zł143.19 Million | 6.07% |
| Other Components | zł1.56 Billion | 66.14% |
| Total Equity | zł2.36 Billion | 100.00% |
Krka d. d Competitors by Market Cap
The table below lists competitors of Krka d. d ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Grupo Aeroportuario del Pacífico S.A.B. de C.V
MX:GAPB
|
$9.47 Billion |
|
China Merchants Shekou Industrial Zone Holdings
SHE:001979
|
$9.47 Billion |
|
Guangzhou Tinci Materials Technology Co Ltd
SHE:002709
|
$9.47 Billion |
|
Empresas Copec S.A.
SN:COPEC
|
$9.48 Billion |
|
UNITED UTILITIES GP ADR/2
F:UUEA
|
$9.46 Billion |
|
Beijing YanDong MicroElectronic Co. Ltd. A
SHG:688172
|
$9.46 Billion |
|
Orkla ASA
OL:ORK
|
$9.45 Billion |
|
Addtech AB (publ.)
ST:ADDT-B
|
$9.45 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Krka d. d's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 2,218,183,000 to 2,359,799,785, a change of 141,616,785 (6.4%).
- Net income of 403,432,225 contributed positively to equity growth.
- Dividend payments of 252,084,611 reduced retained earnings.
- Share repurchases of 61,585,954 reduced equity.
- Other comprehensive income increased equity by 157,766,648.
- Other factors decreased equity by 105,911,523.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | zł403.43 Million | +17.1% |
| Dividends Paid | zł252.08 Million | -10.68% |
| Share Repurchases | zł61.59 Million | -2.61% |
| Other Comprehensive Income | zł157.77 Million | +6.69% |
| Other Changes | zł-105.91 Million | -4.49% |
| Total Change | zł- | 6.38% |
Book Value vs Market Value Analysis
This analysis compares Krka d. d's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 14.99x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 36.50x to 14.99x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2010-12-31 | zł31.12 | zł1136.00 | x |
| 2011-12-31 | zł33.89 | zł1136.00 | x |
| 2012-12-31 | zł37.23 | zł1136.00 | x |
| 2013-12-31 | zł40.34 | zł1136.00 | x |
| 2014-12-31 | zł41.22 | zł1136.00 | x |
| 2015-12-31 | zł43.16 | zł1136.00 | x |
| 2016-12-31 | zł44.54 | zł1136.00 | x |
| 2017-12-31 | zł46.15 | zł1136.00 | x |
| 2018-12-31 | zł48.04 | zł1136.00 | x |
| 2019-12-31 | zł52.41 | zł1136.00 | x |
| 2020-12-31 | zł55.52 | zł1136.00 | x |
| 2021-12-31 | zł61.09 | zł1136.00 | x |
| 2022-12-31 | zł68.19 | zł1136.00 | x |
| 2023-12-31 | zł69.85 | zł1136.00 | x |
| 2024-12-31 | zł72.06 | zł1136.00 | x |
| 2025-12-31 | zł75.79 | zł1136.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Krka d. d utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 17.10%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 19.76%
- • Asset Turnover: 0.67x
- • Equity Multiplier: 1.29x
- Recent ROE (17.10%) is above the historical average (13.86%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2010 | 16.26% | 16.93% | 0.68x | 1.41x | zł65.85 Million |
| 2011 | 14.30% | 15.14% | 0.70x | 1.35x | zł48.98 Million |
| 2012 | 12.91% | 13.99% | 0.70x | 1.31x | zł36.01 Million |
| 2013 | 12.98% | 14.39% | 0.68x | 1.32x | zł39.71 Million |
| 2014 | 12.31% | 13.95% | 0.66x | 1.33x | zł31.16 Million |
| 2015 | 11.27% | 13.59% | 0.64x | 1.29x | zł17.77 Million |
| 2016 | 7.51% | 9.23% | 0.61x | 1.32x | zł-35.89 Million |
| 2017 | 10.26% | 12.05% | 0.66x | 1.29x | zł3.93 Million |
| 2018 | 11.35% | 13.11% | 0.67x | 1.29x | zł20.83 Million |
| 2019 | 14.75% | 16.44% | 0.68x | 1.31x | zł79.11 Million |
| 2020 | 16.69% | 18.96% | 0.69x | 1.28x | zł116.66 Million |
| 2021 | 16.23% | 19.75% | 0.62x | 1.33x | zł118.69 Million |
| 2022 | 17.15% | 21.15% | 0.64x | 1.27x | zł151.43 Million |
| 2023 | 14.52% | 17.38% | 0.65x | 1.28x | zł97.74 Million |
| 2024 | 16.09% | 18.69% | 0.67x | 1.28x | zł135.17 Million |
| 2025 | 17.10% | 19.76% | 0.67x | 1.29x | zł167.45 Million |
Industry Comparison
This section compares Krka d. d's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $554,002,000
- Average return on equity (ROE) among peers: -2.10%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Krka d. d (KRK) | zł2.64 Billion | 16.26% | 0.26x | $9.47 Billion |
| Celon Pharma SA (CLN) | $554.00 Million | -2.10% | 0.28x | $213.32 Million |
About Krka d. d
Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company offers prescription pharmaceuticals for cardiovascular, central nervous system, gastrointestinal tract, pain, diabetes, an… Read more